The dysfunctional regulation of the DAT can contribute to dopamine-related disorders, potentially leading to PD, schizophrenia, attention deficit hyperactivity disorder, and other central nervous system pathologies 26-28. Here, SLC6A3 is linked to Parkinson disease.